Repro Med Systems (KRMD) Tops Q1 EPS by 2c ; Offers Guidance

Repro Med Systems (NASDAQ: KRMD) reported Q1 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.45 million.

GUIDANCE:

Repro Med Systems sees FY2024 revenue of $31.2-32.2 million, versus the consensus of $31.62 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy
• INVO Fertility (IVF) Tops Q2 EPS by 105c